Mastering Endocrine Disorders: Your FNP Board Prep Roadmap to Thyroid, Adrenal, and Diabetes

Endocrinology · 5 min read · June 23, 2026

Demystifying Endocrinology for Your FNP Boards

Hello future FNPs! Endocrinology often feels like a vast and complex subject, but it's crucial for your board exams. The good news? You don't need to be an endocrinologist to pass. You need to understand the core concepts, common presentations, and management principles that an FNP encounters daily. Let's simplify some of the most frequently tested endocrine topics: thyroid, adrenal, and diabetes.

Thyroid Disorders: Hyper, Hypo, and Nodules

Thyroid disorders are incredibly common in primary care, making them high-yield for your boards. You'll need to differentiate between hypothyroidism and hyperthyroidism and understand the initial steps for evaluating thyroid nodules.

Hypothyroidism

Pathophysiology: Often Hashimoto's thyroiditis (autoimmune destruction of the thyroid gland), leading to decreased thyroid hormone production. It's the most common cause of hypothyroidism in iodine-sufficient regions.
Clinical Presentation: Think "slowed down" metabolism. Patients may report fatigue, weight gain, cold intolerance, constipation, dry skin, hair loss, and bradycardia. In severe, untreated cases, it can lead to myxedema coma.
Diagnosis: Elevated TSH (Thyroid-Stimulating Hormone) and low free T4 (thyroxine). TSH is the most sensitive screening test.
Treatment: Levothyroxine (synthetic T4). Start low and go slow, especially in older adults or those with cardiac disease. Dosing is titrated based on TSH levels, typically every 4-6 weeks until stable.

Hyperthyroidism

Pathophysiology: Most commonly Graves' disease (autoimmune stimulation of the thyroid gland), leading to excessive thyroid hormone production. Other causes include toxic multinodular goiter or thyroiditis.
Clinical Presentation: Think "sped up" metabolism. Patients may experience weight loss despite increased appetite, heat intolerance, palpitations, anxiety, tremor, diarrhea, and tachycardia. Graves' disease can also present with exophthalmos (bulging eyes) and pretibial myxedema.
Diagnosis: Suppressed TSH and elevated free T4 and/or free T3.
Treatment: Options include antithyroid medications (e.g., methimazole, propylthiouracil), radioactive iodine ablation, or thyroidectomy. Referral to an endocrinologist is often warranted.

Thyroid Nodules

Evaluation: The primary concern with a thyroid nodule is malignancy. Initial evaluation includes a TSH level and a thyroid ultrasound. If TSH is suppressed, a radioactive iodine uptake scan can help differentiate hot (benign) from cold (potentially malignant) nodules. If TSH is normal or elevated, or if ultrasound features are suspicious, Fine Needle Aspiration (FNA) biopsy is indicated.

Clinical Pearl: For thyroid disorders, remember the TSH-T4 relationship. In primary hypothyroidism, TSH is high, T4 is low. In primary hyperthyroidism, TSH is low, T4 is high. This is a common board question!

Adrenal Gland Disorders: Addison's and Cushing's

The adrenal glands produce vital hormones like cortisol, aldosterone, and androgens. Imbalances can lead to significant clinical issues.

Adrenal Insufficiency (Addison's Disease)

Pathophysiology: Primary adrenal insufficiency is often autoimmune destruction of the adrenal cortex, leading to decreased production of cortisol and aldosterone. Secondary adrenal insufficiency is due to pituitary ACTH deficiency, affecting only cortisol.
Clinical Presentation: Chronic fatigue, weakness, weight loss, anorexia, nausea/vomiting, abdominal pain, and hyperpigmentation (in primary Addison's due to elevated ACTH). Patients may also have hypotension and hyponatremia.
Diagnosis: Morning cortisol level (low) and elevated ACTH (in primary). The ACTH stimulation test (Cosyntropin test) is the definitive diagnostic test.
Treatment: Glucocorticoid replacement (e.g., hydrocortisone) and, for primary Addison's, mineralocorticoid replacement (fludrocortisone).

Cushing's Syndrome

Pathophysiology: Excessive cortisol production. Can be exogenous (most common, due to long-term corticosteroid use) or endogenous (adrenal tumor, pituitary adenoma causing excess ACTH, or ectopic ACTH production).
Clinical Presentation: Central obesity, moon facies, buffalo hump, thin extremities, purple striae, easy bruising, hypertension, hyperglycemia, muscle weakness, and emotional lability.
Diagnosis: Initial screening tests include a 24-hour urinary free cortisol (elevated) or a dexamethasone suppression test (failure to suppress cortisol). Further workup determines the cause.
Treatment: Depends on the cause. Discontinuation of exogenous steroids, surgical removal of tumors, or medications to block cortisol production.

Board Tip: Always consider iatrogenic Cushing's (from steroid use) as the most common cause. If a patient is on chronic steroids and develops Cushingoid features, this is your answer!

Diabetes Mellitus: Type 1, Type 2, and Management Essentials

Diabetes is a cornerstone of primary care and will be heavily tested. Focus on diagnostic criteria, acute complications, and general management principles.

Type 1 Diabetes Mellitus (T1DM)

Pathophysiology: Autoimmune destruction of pancreatic beta cells, leading to absolute insulin deficiency.
Clinical Presentation: Often acute onset, typically in children or young adults. Polyuria, polydipsia, polyphagia, weight loss, and fatigue. Can present with Diabetic Ketoacidosis (DKA).
Diagnosis: Fasting plasma glucose ≥126 mg/dL, random plasma glucose ≥200 mg/dL with symptoms, A1C ≥6.5%, or 2-hour plasma glucose ≥200 mg/dL during an oral glucose tolerance test. Presence of autoantibodies (e.g., GAD65, islet cell antibodies) supports T1DM.
Treatment: Lifelong insulin replacement.

Type 2 Diabetes Mellitus (T2DM)

Pathophysiology: Progressive insulin resistance and eventual pancreatic beta-cell dysfunction, leading to relative insulin deficiency.
Clinical Presentation: Often insidious onset, typically in adults, but increasingly seen in adolescents. Can be asymptomatic for years. Similar symptoms to T1DM but often less severe initially. Frequent infections, slow wound healing, blurred vision.
Diagnosis: Same criteria as T1DM.
Treatment: Lifestyle modifications (diet, exercise) are foundational. First-line pharmacotherapy is metformin. Other agents include sulfonylureas, GLP-1 receptor agonists, SGLT2 inhibitors, DPP-4 inhibitors, and eventually insulin.

Acute Complications

DKA (Diabetic Ketoacidosis): More common in T1DM. Characterized by hyperglycemia, metabolic acidosis, and ketonemia. Presents with Kussmaul respirations, fruity breath, abdominal pain, nausea/vomiting, altered mental status.
HHS (Hyperosmolar Hyperglycemic State): More common in T2DM. Characterized by severe hyperglycemia, extreme dehydration, and hyperosmolarity, without significant ketoacidosis. Presents with profound dehydration, altered mental status, and neurological deficits.

Clinical Pearl: When managing T2DM, remember that metformin is almost always the first-line oral agent unless contraindicated (e.g., severe renal impairment). It reduces hepatic glucose production and improves insulin sensitivity.

Key Takeaways for Your Boards

Endocrinology is about understanding the delicate balance of hormones. When preparing for your boards, focus on:

Pathophysiology: What's going wrong with the hormones?
Classic Presentations: How do these imbalances manifest in patients?
Diagnostic Tests: Which tests confirm the diagnosis?
First-Line Treatments: What's the initial management strategy?
Acute Complications: How do you recognize and manage emergencies?

You've got this! Breaking down these complex topics into manageable chunks will build your confidence. Keep reviewing, keep practicing, and trust in your ability to master this material. You're well on your way to becoming an outstanding FNP.

Ready to put your knowledge to the test? Visit store.thefnpreview.com for comprehensive board prep resources, including thousands of practice questions designed to mimic the actual exam. Your success is within reach!